Sign in

CIK 0000318154

  • Large accelerated filer
Ticker
AMGN
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
953540776
Phone
+1 805-447-1000
Business address
ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA, 91320
  1. 3 Insider Initial Statement of Ownership
  2. 4 Open-market buy 10% owner bought 165,529 shares at $302.06 ($49,999,938)
  3. 4 Grant or award Director acquired 282.42 shares (grant or award)
  4. 4 Grant or award Director acquired 760 shares (grant or award)
  5. 4 Grant or award Director acquired 347.6 shares (grant or award)
  6. 3/A Insider 3/A
  7. 3 Insider Initial Statement of Ownership
  8. 4 Grant or award Director acquired 837 shares (grant or award)
  9. 4 Grant or award Director acquired 837 shares (grant or award)
  10. 4 Grant or award Director acquired 837 shares (grant or award)
  11. 4 Grant or award Director acquired 837 shares (grant or award)
  12. 4 Grant or award Director acquired 837 shares (grant or award)
  13. 4 Grant or award Director acquired 837 shares (grant or award)
  14. 4 Grant or award Director acquired 837 shares (grant or award)
  15. 4 Grant or award Director acquired 837 shares (grant or award)
  16. 4 Grant or award Director acquired 837 shares (grant or award)
  17. 4 Grant or award Director acquired 837 shares (grant or award)
  18. 4 Open-market sale Director sold 1,000 shares at $250.59 ($250,590)
  19. 4 Open-market sale SVP & CCO sold 2,500 shares at $252.51 ($631,272)
  20. 4 Open-market sale Director sold 250 shares at $251.78 ($62,945)

Page 23 of 99 · 1,961 filings